Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

In a powerful example of how compassion, clinical expertise, and artificial intelligence can come together to change lives, a ...

Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announces the completion of the one-year follow-up for all patients enrolled in ...

Neuralink accelerates its brain-computer interface ambitions with a major funding boost and ongoing human trials.

HOUSTON, TX, USA and CHICAGO, IL, USA I May 29, 2025 I RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on ...

Colossal Biosciences has successfully brought back the dire wolf, a species that disappeared from Earth approximately 13,000 ...

Chinese scientists have successfully constructed a 300-kilometre fully connected quantum secure direct communication (QSDC) network, marking a major breakthrough in the field, the Beijing Academy of ...

Neuralink, a neurotechnology company founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, raised $650M through its latest Series E ...

A Mexico City startup has achieved the Western Hemisphere's first SaMD regulatory approval for its proprietary AI-powered ...

Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q1 2025 investor letter.

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Researchers from Dongguk University, Seoul, South Korea, have achieved a significant breakthrough in lithium-ion battery technology by developing a novel hybrid anode material.